CSII Cardiovascular Systems Inc

Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at the William Blair 3rd Annual Emerging Growth Stock Conference on October 6 at the Waldorf-Astoria Hotel in New York. President and Chief Executive Officer David L. Martin and Chief Financial Officer Laurence L. Betterley will provide an overview of the company and its strategies for growth.

WHEN:

 

William Blair 3rd Annual Emerging Growth Stock Conference

October 6; 8:45 a.m. EST Waldorf-Astoria Hotel New York  

WEBCAST:

To listen to a live webcast of the presentation, go to the investor information section of the company’s Web site, www.csi360.com, and click on the webcast icon.

 

If you have any difficulty accessing the webcast, please contact

Mick Forgey: (612) 455-1789; mforgey@psbpr.com

 

CONTACTS:

Cardiovascular Systems, Inc.:   Padilla Speer Beardsley: Investor Relations Nancy A. Johnson (651) 259-2800 (612) 455-1745

njohnson@psbpr.com

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease. The company's Diamondback 360® PAD System is capable of treating a broad range of plaque types both above and below the knee, including calcified vessel lesions, and addresses many of the limitations associated with existing treatment alternatives. In August 2007, the U.S. FDA granted 510(k) clearance for the use of the Diamondback 360° as a therapy for PAD (peripheral arterial disease), and CSI commenced a U.S. product launch in September 2007. The Diamondback 360° system has been adopted by nearly 600 hospitals across the United States. For more information visit the company's Web site at www.csi360.com.